Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Cash position?? It's KEY folks...3 BIG NR's is a helluva ..
View:
Post by SouthernTierTom on Jan 22, 2021 8:24am

Cash position?? It's KEY folks...3 BIG NR's is a helluva ..

effort!

Losses of about 10 MILL over the last 9 months??  Is that correct?

They can't have much cash left for the FDA gambit!

Toooo bhaaaad these 3 BIG efforts didn't move the SP much ; - (

HEY..."effort" noted..."clear the track..they'll need to add to their $tack" - ALL IMHO ; - )
Comment by charlierock on Jan 22, 2021 8:44am
The company's cash position is one of my biggest concerns. Do not want to see more dilution.
Comment by socalbob on Jan 22, 2021 9:10am
Unfortunately Tom you are probably correct.  Seen this exact playbook by TLT before of rapid fire press releases to try to move the stock just before the eventual news of a horribly dilutive cash raise.  The extension of the warrants shows Mgt. hope and expectation of price movement to generate funds from warrants exercised at higher levels than the current price. But, the market is not ...more  
Comment by BencrosMum on Jan 22, 2021 9:28am
They don't need cash yet!!! but 3 NRs before they dole out options to themselves after hours is a little scary. Hopefully they are a little smart and forgo the presents this year  
Comment by floatinketucky on Jan 22, 2021 9:33am
I agree, the cash postioin is strong. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250